openPR Logo
Press release

Serotonin Syndrome Market 2023 Top Key Players are AstraZeneca Plc., Eli Lilly and Company, Forest Laboratories Inc., GlaxoSmithKline plc, Johnson & Johnson

02-25-2019 08:07 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

/ PR Agency: Market Research Future
Serotonin Syndrome Market

Serotonin Syndrome Market

The report for Global Serotonin Syndrome Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance.

The Serotonin Syndrome Market is expected to reach $ 400 million by the end of 2023, this market is projected to growing at a CAGR of ~ 2.3 % during 2017-2023.

Serotonin syndrome is a group of symptoms such as high body temperature, agitation, increased reflexes, tremor, sweating, dilated pupils, diarrhoea etc. due to use of serotonergic drugs. Serious complications such as seizures and extensive muscle breakdown may occur which may lead to death. The 1984, Libby Zion case is an example of death from serotonin syndrome. Serotonin syndrome is typically caused by synergistic effect of two or more serotonergic drugs which generally include selective serotonin reuptake inhibitor (SSRI), serotonin norepinephrine reuptake inhibitor (SNRI), monoamine oxidase inhibitor (MAOI), tricyclic antidepressants (TCAs), amphetamines etc. Other drugs with a high propensity of causing serotonin syndrome are dextromethorphan, buspirone, L-tryptophan, St. John's wort, metoclopramide, ondansetron etc. There is no laboratory test to confirm the diagnosis of serotonin syndrome.

The treatment for serotonin syndrome consists of discontinuing medications contributing to the condition. For serious cases, other treatments for managing associated symptoms may be used. For serious cases with a threat to life gastrointestinal decontamination using activated charcoal is performed. Sedatives such as benzodiazepines are used for agitated patients. High fever is a common symptom of serotonin syndrome which reaches extremely high temperatures greater than forty centigrade. To control hyperthermia cooling measures may be needed. Serotonin antagonist such as cyproheptadine may be needed.

The market restraints are the low number of cases and equally low number of fatalities associated with the syndrome with less than 1% cases consuming serotonin syndrome causing drugs developing the diseases. Mild symptoms occur in about 15% of SSRI overdoses.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4075 .

Key players of Global Serotonin syndrome market:
Key players profiled in the report are AstraZeneca Plc., Eli Lilly and Company, Forest Laboratories Inc., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Pfizer, Inc. and Sanofi S.A., Ciron Drugs & Pharmaceuticals Pvt. Ltd. and others.
Segments:
The global serotonin syndrome market is segmented on the basis of drug treatment, and end users. Based on drug treatment, the market has been segmented as serotonin antagonists, supportive care (Muscle relaxants, the control of autonomic instability, anti-hyperthermics, antihypertensive and others. Based on the end users, the market has been segmented as hospitals, point of care and others.

Regional analysis:
US accounts for the maximum market share due to greater use of medications and greater expenditure on healthcare. The faster market uptake of new technology and devices in the US is also an important driver of the market for global serotonin syndrome diagnosis and treatment. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is expected to have the most future potential and it is estimated to be led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The regions of Africa are expected to witness a moderate growth due to poor economic and political conditions and poor healthcare penetration.

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Serotonin Syndrome Market 2023 Top Key Players are AstraZeneca Plc., Eli Lilly and Company, Forest Laboratories Inc., GlaxoSmithKline plc, Johnson & Johnson here

News-ID: 1612808 • Views:

More Releases from Market Research Future

Global Small Boat Industry Sees Growing Demand Amid Rising Recreational Boating and Coastal Activities
Global Small Boat Industry Sees Growing Demand Amid Rising Recreational Boating …
As per the latest analysis by Market Research Future, the Small Boats Market Size was estimated at 17.12 (USD Billion) in 2024. The Small Boats Market Industry is expected to grow from 17.88 (USD Billion) in 2025 to 26.41 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 4.43% during the forecast period (2025 - 2034). The global small boat industry is witnessing significant growth, driven
Automotive Trim Market Attaining USD 193.22 Billion till 2034 | Innovations Redefine Vehicle Aesthetics and Functionality
Automotive Trim Market Attaining USD 193.22 Billion till 2034 | Innovations Rede …
As per the latest analysis by Market Research Future, the Automotive Trim Market Size was estimated at 140.30 (USD Billion) in 2024. The Automotive Trim Market Industry is expected to grow from 144.87 (USD Billion) in 2025 to 193.22 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 3.25% during the forecast period (2025 - 2034). The automotive industry is witnessing a significant transformation in vehicle
Leading Automotive Technology Firms Expand Fuel Level Sensor Solutions for Next-Generation Vehicles | Robert Bosch Gmbh, Technoton
Leading Automotive Technology Firms Expand Fuel Level Sensor Solutions for Next- …
As per the latest analysis by Market Research Future, Automotive Fuel Level Sensor Market Size was valued at USD 5,788.04 million in 2024. The Automotive Fuel Level Sensor market industry is projected to grow from USD 6,008.32 million in 2025 to USD 9,201.90 million by 2035, exhibiting a compound annual growth rate (CAGR) of 4.35% during the forecast period (2024 - 2035). With the global automotive industry focused on precision,
Valet Parking Technology Gains Momentum as Urban Mobility and Smart Infrastructure Evolve | Market Growth with 15.62% CAGR
Valet Parking Technology Gains Momentum as Urban Mobility and Smart Infrastructu …
As per the latest analysis by Market Research Future, the Valet Parking Technology Market Size was estimated at 1.41 (USD Billion) in 2024. The Valet Parking Technology Market Industry is expected to grow from 1.63 (USD Billion) in 2025 to 6.01 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 15.62% during the forecast period (2025 - 2034). Valet parking technology is emerging as a transformative

All 5 Releases


More Releases for Serotonin

Serotonin Acquires Unparalleled to Create 1m+ EBITDA Marketing Powerhouse
Acquisition marks the launch of Serotonin's buy-and-build strategy to consolidate digital marketing services at scale. Image: https://www.globalnewslines.com/uploads/2025/08/281952c2eb2b091e8b4ac31ab1bb3267.jpg Manchester, UK - Serotonin [https://www.serotonin.co.uk/] (www.serotonin.co.uk) has officially acquired Unparalleled, a digital agency known for its expertise in ecommerce and performance marketing. The move creates a new force in the North West's marketing scene, with combined operations now generating in excess of 1 million in EBITDA annually. Unparalleled brings a team of 12 experts across to
Serotonin Supplement Market is on an Upward Growth Curve
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Serotonin Supplement Market- (By Functionality (Depression Relief, Insomnia Relief, Appetite Gaining, Mood Disorder Treatment, Weight Loss, and Cognitive Health Improvement), By Form (Tablets / Pills, Capsules, Liquid, Powder/ Chewable and Others), By Sales Channel (Hypermarkets / Supermarkets, Specialty Stores, E-commerce, Drug Stores & Pharmacies, Health & Wellness Stores, Convenience Stores, Departmental Stores and Others), By
Serotonin Supplement Market Know the Scope and Trends
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Serotonin Supplement Market- (By Functionality (Depression Relief, Insomnia Relief, Appetite Gaining, Mood Disorder Treatment, Weight Loss, and Cognitive Health Improvement), By Form (Tablets / Pills, Capsules, Liquid, Powder/ Chewable and Others), By Sales Channel (Hypermarkets / Supermarkets, Specialty Stores, E-commerce, Drug Stores & Pharmacies, Health & Wellness Stores, Convenience Stores, Departmental Stores and Others), By
Global Antidepressants Drugs Market Size - By Product Type(Tricyclic Antidepress …
Antidepressants Drugs Market Insights: Trends, Drivers, and Outlook 2024 - 2031 Antidepressants Drugs Market Scope: Unveiling Today's Trends Antidepressant drugs are medications designed to alleviate symptoms of depression and mood disorders. The global antidepressants market has been witnessing significant growth, driven by increasing awareness and diagnosis of mental health issues, along with a rising prevalence of depression and anxiety disorders. As healthcare systems prioritize mental health, the demand for effective pharmacological treatments
Serotonin-Dopamine Activity Modulators Market Insights, Forecast to 2031
The report extensively examines the global Serotonin-Dopamine Activity Modulators market while focusing on the leading companies and their business strategies, geographical growth, market segmentation, competitive environment, production, price, and cost structures. Each section of the research report has been carefully designed to examine important facets of the global market for Serotonin-Dopamine Activity Modulators . For instance, the market dynamics section delves deeply into the trends, opportunities, and drivers influencing the
Global Serotonin Syndrome Market Size, Status and Forecast 2019-2025
Market Research Report Store offers a latest published report on Serotonin Syndrome Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 158 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/632687/global-serotonin-syndrome-market-size-status   Serotonin syndrome is a group of symptoms